Biorestorative Therapies Underway With Phase 2 Clinical Trial With Stem Cell-Based Brtx-100

BioRestorative Therapies underway with Phase 2 clinical trial with stem cell-based BRTX-100

Proactive Investors

$BRTX's Phase II Clinical Trial Is Underway To Treat Chronic Back Pain: Interview With Dr. Lipetz!

Benzinga Partner Studio

$BRTX's Drug Candidate BRTX-100 Excels In Safety Test, Advances To Phase 2 And Expands Pipeline

Benzinga Partner Studio

$BRTX: Insights From A Specialist On Stem Cell-Based Therapies And The Need For Spinal Care Reform

Benzinga Partner Studio

$BRTX Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs

Benzinga Partner Studio

$BRTX Interview with Lance Alstodt, CEO & Chairman & Francisco Silva, Chief Scientist & VP, R&D

Benzinga Partner Studio

$BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome ✊

Benzinga Partner Studio

Phase 2 Clinical Trial Update 3

Phase I clinical trial using stem cells to combat Parkinson’s disease progression

BioRestorative Therapies, Inc. (OTC Pink: BRTX)

Emerging Growth Conference

BioRestorative Therapies, Inc. - BRTX Interview, Lance Alstodt, CEO

BRTX Official Video

How BioRestorative is Changing Lives with Stem Cell Therapy

Molecular Biosciences Professor Dr. Tore Bengtsson Weighs in on $BRTX's Metabolic Health Pursuits

Benzinga Partner Studio

Stem Cells in A New Era of Cell based Therapies - Creative Biolabs

Creative Biolabs

The Basics of Stem Cell Therapy - Clinical Trials, Research, Risks & Treatment Options in 2024

The Stem Cell Regeneration Center

Is Stem Cell Therapy FDA Approved? Dr. Bharara Explains.

VSI (Virginia Spine Institute)

How do stem cells work in the body?

Science Animated

New Stem Cell Therapy for COVID-19 Finds Success in Clinical Trial at Baptist Health